e-learning
resources
Monograph
2005
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The hepatopulmonary syndrome
P. Schenk
Source:
Eur Respir Mon; 2006: 34: 112–128
Journal Issue:
Pulmonary Manifestations of Systemic Diseases
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Schenk. The hepatopulmonary syndrome. Eur Respir Mon; 2006: 34: 112–128
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
IgG4 disease and the lung
Dyspnoea in a patient with Osler's disease
Aortic dilation, Marfan disease and aortic dissection: links with OSA and impact of treatment
Related content which might interest you:
Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview
Source: Eur Respir Rev 2012 21:223-233
Year: 2012
The lung in liver disease: hepatopulmonary syndrome and portopulmonary hypertension
Source: Eur Respir Monogr 2019; 86: 262-277
Year: 2019
Hepatopulmonary syndrome among patients of cirrhosis of liver and portal hypertension
Source: Annual Congress 2007 - Pulmonary circulation
Year: 2007
Liver transplantation in hepatopulmonary syndrome and portopulmonary hypertension
Source: Annual Congress 2003 - Pulmonary-hepatic disorders (PHD) - recommendations of the PHD ERS Task Force for management of hepatopulmonary syndrome and portopulmonary hypertension
Year: 2003
Association between portopulmonary hypertension and hepatopulmonary syndrome in cirrhotics, candidates to hepatic transplantation
Source: Annual Congress 2003 - Pulmonary hypertension
Year: 2003
Intravenous iloprost bridging to orthotopic liver transplantation in portopulmonary hypertension
Source: Eur Respir J 2004; 24 : 703-707
Year: 2004
Hepatopulmonary syndrome following portopulmonary hypertension
Source: Eur Respir J 2007; 29: 1277-1280
Year: 2007
Portopulmonary hypertension: a further clue to pathogenesis?
Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension
Year: 2005
Resolution of portopulmonary hypertension (POPH) following liver transplantation
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012
Portopulmonary hypertension
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=129
Year: 2005
Hepatopulmonary syndrome in children with chronic liver disease
Source: Eur Respir J 2005; 26: Suppl. 49, 354s
Year: 2005
The metabolic syndrome and pulmonary hypertension
Source: Virtual Congress 2020 – Pulmonary vascular diseases
Year: 2020
Pulmonary arterial hypertension associated with congenital heart disease
Source: Eur Respir Rev 2012 21: 328-337
Year: 2012
Pulmonary arterial hypertension masquerading as severe refractory asthma
Source: Eur Respir J 2008; 32: 513-516
Year: 2008
Pulmonary veno-occlusive disease in myeloproliferative disorder
Source: Eur Respir J 2009; 33: 213-216
Year: 2009
An autopsy case of portopulmonary hypertension associated with idiopathic portal hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013
Development of hepatopulmonary syndrome during combination therapy for portopulmonary hypertension
Source: Eur Respir J, 53 (1) 1801880; 10.1183/13993003.01880-2018
Year: 2019
Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension
Source: Eur Respir J 2011; 37: 472
Year: 2011
Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease
Source: Eur Respir J 2009; 34: 1348-1356
Year: 2009
Pulmonary hypertension is common in end-stage sarcoidosis
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept